Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge Infection

The flatworm Schistosoma mansoni is a blood fluke parasite that causes schistosomiasis, a debilitating disease that occurs throughout the developing world. Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to co...

Full description

Saved in:
Bibliographic Details
Main Authors: Vicente P. Martins, Carina S. Pinheiro, Barbara C. P. Figueiredo, Natan R. G. Assis, Suellen B. Morais, Marcelo V. Caliari, Vasco Azevedo, William Castro-Borges, R. Alan Wilson, Sergio C. Oliveira
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2012/962538
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545300842020864
author Vicente P. Martins
Carina S. Pinheiro
Barbara C. P. Figueiredo
Natan R. G. Assis
Suellen B. Morais
Marcelo V. Caliari
Vasco Azevedo
William Castro-Borges
R. Alan Wilson
Sergio C. Oliveira
author_facet Vicente P. Martins
Carina S. Pinheiro
Barbara C. P. Figueiredo
Natan R. G. Assis
Suellen B. Morais
Marcelo V. Caliari
Vasco Azevedo
William Castro-Borges
R. Alan Wilson
Sergio C. Oliveira
author_sort Vicente P. Martins
collection DOAJ
description The flatworm Schistosoma mansoni is a blood fluke parasite that causes schistosomiasis, a debilitating disease that occurs throughout the developing world. Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control schistosomiasis is through immunization with an antischistosomiasis vaccine combined with drug treatment. In the search for potential vaccine candidates, numerous tegument antigens have been assessed. As the major interface between parasite and mammalian host, the tegument plays crucial roles in the establishment and further course of schistosomiasis. Herein, we evaluated the potential of a GPI fraction, containing representative molecules located on the outer surface of adult worms, as vaccine candidate. Immunization of mice with GPI-anchored proteins induced a mixed Th1/Th2 type of immune response with production of IFN-γ and TNF-α, and low levels of IL-5 into the supernatant of splenocyte cultures. The protection engendered by this vaccination protocol was confirmed by 42% reduction in worm burden, 45% reduction in eggs per gram of hepatic tissue, 29% reduction in the number of granulomas per area, and 53% reduction in the granuloma fibrosis. Taken together, the data herein support the potential of surface-exposed GPI-anchored antigens from the S. mansoni tegument as vaccine candidate.
format Article
id doaj-art-4661a143656e4106abf7722cdbd0a90f
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-4661a143656e4106abf7722cdbd0a90f2025-02-03T07:26:07ZengWileyClinical and Developmental Immunology1740-25221740-25302012-01-01201210.1155/2012/962538962538Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge InfectionVicente P. Martins0Carina S. Pinheiro1Barbara C. P. Figueiredo2Natan R. G. Assis3Suellen B. Morais4Marcelo V. Caliari5Vasco Azevedo6William Castro-Borges7R. Alan Wilson8Sergio C. Oliveira9Departamento de Bioquímica, Imunologia do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, BrazilDepartamento de Bioquímica, Imunologia do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, BrazilDepartamento de Bioquímica, Imunologia do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, BrazilDepartamento de Bioquímica, Imunologia do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, BrazilDepartamento de Bioquímica, Imunologia do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, BrazilDepartamento de Patologia Geral do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, BrazilDepartamento de Biologia Geral do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, BrazilDepartamento de Ciências Biológicas, Universidade Federal de Ouro Preto, 35400-000 Ouro Preto, MG, BrazilCentre for Immunology & Infection, Department of Biology, University of York, Heslington, York YO10 5DD, UKDepartamento de Bioquímica, Imunologia do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, BrazilThe flatworm Schistosoma mansoni is a blood fluke parasite that causes schistosomiasis, a debilitating disease that occurs throughout the developing world. Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control schistosomiasis is through immunization with an antischistosomiasis vaccine combined with drug treatment. In the search for potential vaccine candidates, numerous tegument antigens have been assessed. As the major interface between parasite and mammalian host, the tegument plays crucial roles in the establishment and further course of schistosomiasis. Herein, we evaluated the potential of a GPI fraction, containing representative molecules located on the outer surface of adult worms, as vaccine candidate. Immunization of mice with GPI-anchored proteins induced a mixed Th1/Th2 type of immune response with production of IFN-γ and TNF-α, and low levels of IL-5 into the supernatant of splenocyte cultures. The protection engendered by this vaccination protocol was confirmed by 42% reduction in worm burden, 45% reduction in eggs per gram of hepatic tissue, 29% reduction in the number of granulomas per area, and 53% reduction in the granuloma fibrosis. Taken together, the data herein support the potential of surface-exposed GPI-anchored antigens from the S. mansoni tegument as vaccine candidate.http://dx.doi.org/10.1155/2012/962538
spellingShingle Vicente P. Martins
Carina S. Pinheiro
Barbara C. P. Figueiredo
Natan R. G. Assis
Suellen B. Morais
Marcelo V. Caliari
Vasco Azevedo
William Castro-Borges
R. Alan Wilson
Sergio C. Oliveira
Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge Infection
Clinical and Developmental Immunology
title Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge Infection
title_full Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge Infection
title_fullStr Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge Infection
title_full_unstemmed Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge Infection
title_short Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge Infection
title_sort vaccination with enzymatically cleaved gpi anchored proteins from schistosoma mansoni induces protection against challenge infection
url http://dx.doi.org/10.1155/2012/962538
work_keys_str_mv AT vicentepmartins vaccinationwithenzymaticallycleavedgpianchoredproteinsfromschistosomamansoniinducesprotectionagainstchallengeinfection
AT carinaspinheiro vaccinationwithenzymaticallycleavedgpianchoredproteinsfromschistosomamansoniinducesprotectionagainstchallengeinfection
AT barbaracpfigueiredo vaccinationwithenzymaticallycleavedgpianchoredproteinsfromschistosomamansoniinducesprotectionagainstchallengeinfection
AT natanrgassis vaccinationwithenzymaticallycleavedgpianchoredproteinsfromschistosomamansoniinducesprotectionagainstchallengeinfection
AT suellenbmorais vaccinationwithenzymaticallycleavedgpianchoredproteinsfromschistosomamansoniinducesprotectionagainstchallengeinfection
AT marcelovcaliari vaccinationwithenzymaticallycleavedgpianchoredproteinsfromschistosomamansoniinducesprotectionagainstchallengeinfection
AT vascoazevedo vaccinationwithenzymaticallycleavedgpianchoredproteinsfromschistosomamansoniinducesprotectionagainstchallengeinfection
AT williamcastroborges vaccinationwithenzymaticallycleavedgpianchoredproteinsfromschistosomamansoniinducesprotectionagainstchallengeinfection
AT ralanwilson vaccinationwithenzymaticallycleavedgpianchoredproteinsfromschistosomamansoniinducesprotectionagainstchallengeinfection
AT sergiocoliveira vaccinationwithenzymaticallycleavedgpianchoredproteinsfromschistosomamansoniinducesprotectionagainstchallengeinfection